After analyzing 12,478 samples / 9,930 patients with lung cancer from 29 studies, it was found that the total variation in NRF2 and KEAP1 genes was 4% and 13%, respectively (Figure 1A). This evidence concerns the gene NFE2L2 and lung cancer.